Ulipristal
Ulipristal (CDB 3236) is a selective progesterone receptor modulator (SPRM) . Ulipristal binds to the progesteron receptor, thereby inhibiting PR-mediated gene expression, and interfering with progesterone activity in the reproductive system[1].
Product Specifications
CAS Number
[159811-51-5]
Product Name Alternative
CDB-3236; Deacetyl CDB-2914
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Progesterone Receptor
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer; Endocrinology
Assay Protocol
https://www.medchemexpress.com/ulipristal.html
Purity
98.0
Solubility
DMSO : ≥ 250 mg/mL
Smiles
CN(C)C1=CC=C([C@]2([H])C([C@]3([H])[C@@](CC[C@]4(O)C(C)=O)([H])[C@]4(C)C2)=C(CC5)C(CC3)=CC5=O)C=C1
Molecular Formula
C28H35NO3
Molecular Weight
433.58
Precautions
H302, H315, H319, H335
References & Citations
[1]LIANA PLES, et al. Is Ulipristal Acetate a Liver Toxic Biomolecule? Toxicity assessment of ulipristal acetate. REV.CHIM. (Bucharest) .
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lcn2, Recombinant, Mouse, aa21-200, His-Tag (Neutrophil gelatinase-associated lipocalin)
Lcn2, Recombinant, Mouse, aa21-200, His-Tag (Neutrophil gelatinase-associated lipocalin)